ANI Pharmaceuticals, Inc.
HealthcareNASDAQ:ANIP · NASDAQ Global Market
+$0.03 today
Vol 0.18M · Avg 0.37M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+30.56%
Period High
$98.81
Period Low
$62.56
Latest
$81.68
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Trulieve Cannabis Corp.
TCNNF
$2.22B
Hisamitsu Pharmaceutical Co., Inc.
HTSUF
$2.04B
Dermapharm Holding SE
DMPHF
$1.96B
Fagron N.V.
ARSUF
$1.95B
Green Thumb Industries Inc.
GTBIF
$1.85B
Tsumura & Co.
TSMRF
$1.73B
Harrow Health, Inc.
NASDAQ:HROW
$1.40B
CanSino Biologics Inc.
CASBF
$1.08B
Tilray Brands, Inc.
NASDAQ:TLRY
$595.63M
BGM Group Ltd.
NASDAQ:BGM
$75.23M
What is the latest ANIP filing?
The latest filing shown is 4 dated Jun 10, 2026.
How many recent filings does ANIP have?
Intrinsic Alpha currently shows 20 recent filings for ANIP.
Explore More
Continue the stock analysis
Jump to another research area for this company.